Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13071 | 798 | 41.1 | 80% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
232 | 19686 | TAMOXIFEN//AROMATASE INHIBITORS//ANASTROZOLE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SERAMS | Author keyword | 20 | 100% | 1% | 9 |
2 | MATH CHEM | Address | 10 | 33% | 3% | 24 |
3 | ESTROGEN RECEPTOR LIGANDS | Author keyword | 5 | 50% | 1% | 7 |
4 | RELATIVE BINDING AFFINITY | Author keyword | 4 | 38% | 1% | 8 |
5 | SERMS | Author keyword | 4 | 13% | 4% | 28 |
6 | ACTIVATION FUNCTION 2 | Author keyword | 3 | 57% | 1% | 4 |
7 | COUNTERPROPAGATION ARTIFICIAL NEURAL NETWORK | Author keyword | 3 | 100% | 0% | 3 |
8 | ONOBRYCHIS EBENOIDES | Author keyword | 3 | 100% | 0% | 3 |
9 | TETRAHYDROFLUORENONE | Author keyword | 3 | 100% | 0% | 3 |
10 | SUBTYPE SELECTIVE LIGAND | Author keyword | 3 | 60% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DIHYDROBENZOXATHIIN SERAMS | 31 | 82% | 2% | 18 |
2 | MULTIFUNCTIONAL MEDICINES | 26 | 41% | 6% | 50 |
3 | DYNAMIC QSAR | 23 | 100% | 1% | 10 |
4 | LARGE DIVERSE SET | 22 | 62% | 3% | 23 |
5 | BASIC SIDE CHAINS | 18 | 83% | 1% | 10 |
6 | LIGAND FLEXIBILITY | 15 | 82% | 1% | 9 |
7 | HAZARD IDENTIFICATION ALGORITHM | 15 | 63% | 2% | 15 |
8 | ER BETA LIGANDS | 15 | 71% | 2% | 12 |
9 | ANTIESTROGENS | 14 | 12% | 14% | 110 |
10 | SERMS | 13 | 34% | 4% | 32 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Molecular aspects of phytoestrogen selective binding at estrogen receptors | 2007 | 48 | 28 | 57% |
Recent advances in the synthesis of raloxifene: A selective estrogen receptor modulator | 2012 | 11 | 52 | 48% |
Estrogen receptors (ER alpha versus ER beta): friends or foes in human biology? | 2014 | 6 | 54 | 20% |
(Q)SARs for predicting effects relating to reproductive toxicity | 2008 | 26 | 62 | 53% |
Recent Advances in Selective Estrogen Receptor Modulators for Breast Cancer | 2009 | 15 | 60 | 55% |
Non-steroidal subtype selective estrogens | 2005 | 41 | 78 | 68% |
Estrogen receptor ligands: a patent review update | 2013 | 4 | 45 | 56% |
Selective Estrogen Receptor Modulator medicinal chemistry at Merck. A review | 2008 | 13 | 37 | 70% |
Structural Overview of the Nuclear Receptor Superfamily: Insights into Physiology and Therapeutics | 2010 | 105 | 151 | 15% |
Versatility or Promiscuity: The Estrogen Receptors, Control of Ligand Selectivity and an Update on Subtype Selective Ligands | 2014 | 1 | 121 | 60% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MATH CHEM | 10 | 33% | 3.0% | 24 |
2 | ROGER ADAMS 461 | 2 | 40% | 0.5% | 4 |
3 | KARO BIO AB | 2 | 23% | 0.9% | 7 |
4 | ATHEROSCLEROSIS ENDOCRINOL | 2 | 16% | 1.1% | 9 |
5 | BIOMED PLICAT UNIT | 1 | 38% | 0.4% | 3 |
6 | CHEM SCREENING SCI MED CHEM | 1 | 100% | 0.3% | 2 |
7 | CHEM SCREENING SCI STRUCT BIOL | 1 | 100% | 0.3% | 2 |
8 | ENVIRONM BIOCHEM CHEM | 1 | 100% | 0.3% | 2 |
9 | TSCA INTERAGENCY TESTING COMM | 1 | 30% | 0.4% | 3 |
10 | COMPUTAT BIOPHYS BIOENGN | 1 | 40% | 0.3% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000247762 | ESTROGEN RECEPTOR BETA//ER BETA//RECEPTOR BIOL SECT |
2 | 0.0000202678 | ESTROGEN RECEPTOR VARIANTS//JC HEUSON CANCEROL MAMMAIRE//SERV HISTOL CYTOL EXPT |
3 | 0.0000174239 | FLUOROESTRADIOL//F 18 FES PET//FES PET |
4 | 0.0000163246 | LEHRSTUHL PHARMAZEUT CHEM 2//GRP RECH ONCOL ENDOCRINOL MOL//PORPHYRIN PLATINUM CONJUGATES |
5 | 0.0000129087 | RALOXIFENE//TISSUE SELECTIVE ESTROGEN COMPLEX//BAZEDOXIFENE |
6 | 0.0000125022 | CENTCHROMAN//DL111 IT//ORMELOXIFENE |
7 | 0.0000103691 | THREE DIMENSIONAL HOLOGRAPHIC VECTOR OF ATOMIC INTERACTION FIELD 3D HOVAIF//COMFA//3D QSAR |
8 | 0.0000101196 | AIB1//STEROID HORMONES SECT//RIP140 |
9 | 0.0000095050 | HERSHBERGER ASSAY//VINCLOZOLIN//NIPPLE RETENTION |
10 | 0.0000094100 | AEBS//ANTIESTROGEN BINDING SITES//ANALOG II |